Pharmacomechanical thrombolysis of experimental pulmonary emboli: Rapid low-dose intraembolic therapy

Chest

Volumn 106, Issue 5, 1994, Pages 1558-1562

  Tapson, V F ^a   Gurbel, P A ^a   Witty, L A ^a   Pieper, K S ^a   Stack, R S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

fibrinogenolysis; pulmonary embolism; thrombolytic therapy

Indexed keywords

ALTEPLASE; FIBRINOGEN; FIBRINOLYTIC AGENT; HEPARIN; THIAMYLAL; UROKINASE;

ANIMAL MODEL; ARTICLE; DOG; DRUG EFFICACY; EXPERIMENTAL MODEL; FIBRINOGEN BLOOD LEVEL; FIBRINOLYTIC THERAPY; INTRAARTERIAL DRUG ADMINISTRATION; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ANGIOGRAPHY; LUNG EMBOLISM; NONHUMAN; PRIORITY JOURNAL;

EID: 0028080893     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.106.5.1558     Document Type: Article

References (20)

1. The Urokinase Pulmonary Embolism Trial A national cooperative study. Circulation 47(suppl 2) 1973 1 108
2. Goldhaber SZ Kessler CM Heit JA Elliott CG Friedenberg WR Heiselman DE Et Al Recombinant tissue-type plasminogen activator versus a novel dosage regimen of urokinase in acute pulmonary embolism: a randomized, controlled, multicenter trial. J Am Coll Cardiol 20 1992 24 30
3. Petitpretz P Simmoneau G Cerrina J Musset D Dreyfus M Vandenbroek MD Et Al Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial. Circulation 70 1984 861 866
4. Gonzalez-Juanatey JR Valdes L Amaro A Iglesias C Alvarez D Acuna JMG Et Al Treatment of massive pulmonary thromboembolism with low intrapulmonary dosages of urokinase: short-term angiographic and hemodynamic evolution. Chest 102 1992 341 346
5. Dickie JK DeGroot WJ Cooley RN Bond TP Guest MM Hemodynamic effects of bolus infusion of urokinase in pulmonary thromboembolism. Am Rev Respir Dis 109 1974 48 56
6. Barberena J Intraarterial infusion of urokinase in the treatment of acute pulmonary thromboembolism: preliminary observations. Am J Roentgenol 140 1983 883 886
7. Schwarz F Stehr H Zimmermann R Manthey J Kubler W Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism. Circulation 71 1985 117 123
8. Leeper K Popovich J Lesser B Adams D Froelich JW Burke MW Et Al Treatment of massive acute pulmonary embolism: the use of low doses of intrapulmonary arterial streptokinase combined with full doses of systemic heparin. Chest 93 1988 234 240
9. Molina JE Hunter DW Yedlicka JW Cerra FB Thrombolytic therapy for postoperative pulmonary embolism. Am J Surg 163 1992 375 381
10. Verstraete M Miller GAH Bounameaux H Charbonnier B Colle JP Lecorf G Et Al Intravenous and intrapulmonary recombinant tissue type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 77 1988 353 360
11. The UKEP Study Multicentre clinical trial on two local regimens of urokinase in massive pulmonary embolism. Eur Heart J 8 1987 2 10
12. Valji K Bookstein JJ Fibrinolysis with intrathrombic injection of urokinase and tissue-type plasminogen activator: results in a new model of subacute venous thrombosis. Invest Radiol 22 1987 23 27
13. Kandarpa K Drinker PA Singer SJ Caramore D Forceful pulsatile local infusion of enzyme accelerates thrombolysis: in vivo evaluation of a new delivery system. Radiology 168 1988 739 744
14. Bookstein JJ Fellmeth B Roberts A Valji K Davis G Machado T Pulsed-spray pharmacornechanical thrombolysis: preliminary clinical results. Am J Roentgenol 152 1989 1097 2000
15. Goldhaber SZ Heit J Sharma GVRK Nagel JS Kim D Parker JA Et Al Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 2 1988 293 298
16. Shiffman F Ducas J Hollett P Israels E Greenberg D Cook R Et Al Treatment of canine embolic pulmonary hypertension with recombinant tissue-type plasminogen activator: efficacy of dosing regimens. Circulation 78 1988 214 220
17. Prewitt RM Shiffman F Greenberg D Cook R Ducas J Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension: effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics. Circulation 79 1989 929 938
18. Levine M Hirsh J Weitz J Cruickshank M Neemah J Turpie AG Et Al A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 98 1990 1473 1479
19. Sane DC Califf RM Topol EJ Stump DC Mark DB Greenberg CS Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management. Ann Intern Med 111 1989 1010 1022
20. Bookstein JJ Seldinger E Accelerated thrombolysis: in vitro evaluation of agents and methods of administration. Invest Radiol 20 1985 731 735